Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Bioventus
BVS
Concentration Risk %
Concentration Risk % at other companies
Burlington Stores
BURL
5%
0.0pp
Burlington Stores
BURL
0.8%
0.0pp
Ulta Beauty, Inc.
ULTA
40%
0.0pp
Ulta Beauty, Inc.
ULTA
4%
0.0pp
Ulta Beauty, Inc.
ULTA
24%
-1.0pp
Expro Group Holdings
XPRO
4.8%
+0.4pp
Segments
By product
See full
Product A
36%
+16.1%
Product C
20%
+11.1%
Product B
15%
+15.4%
Product D
7%
0.0%
Product E
6%
-14.3%
Other financials
Income statement
See full
Revenue
$153.2M
+3.8%
Gross profit
$105.7M
+3.5%
Operating income
$19.1M
+4.1%
Net income
$33.4M
+348%
EPS (diluted)
$0.47
+327%
Balance sheet
See full
Cash & equivalents
$29.5M
-10.5%
Total debt
$263.7M
-26.9%
Total equity
$228.3M
+41.6%
Total assets
$673.3M
-4.7%
Cash flow
See full
Operating cash flow
$19.9M
-23.4%
CapEx
$960.0K
+40.6%
Free cash flow
$18.9M
-25.1%
Valuation
See full
Market cap
$1.19B
+156%
Enterprise value
$1.42B
+79.7%
P/E
21.8×
—
P/S
2×
+1.2×
Profitability
See full
Gross margin
68.7%
+1.1pp
Operating margin
10%
—
Net margin
9.4%
+9.2pp
FCF margin
16.2%
+10.2pp
Returns & leverage
See full
Return on equity
28%
+27.5pp
Debt / equity
1.2×
-1.1×
Current ratio
1.7×
+0.2×
Watchlist
Screener
Filings
Earnings
Charts